Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 73 articles: HTML format Text format

Single Articles

June 2018
1. IKOMA N, Hofstetter WL, Estrella JS, Das P, et al
   The ypT category does not impact overall survival in node negative gastric cancer.
   J Surg Oncol. 2018 Jun 27. doi: 10.1002/jso.25081.
   PubMed     Text format     Abstract available
   
   
   
2. YU JJ, Li JD, Yang T
   Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer.
   J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25070.
   PubMed     Text format    
   
   
   
3. THIELS CA, Ikoma N, Fournier K, Das P, et al
   Repeat staging laparoscopy for gastric cancer after preoperative therapy.
   J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25094.
   PubMed     Text format     Abstract available
   
   
   
4. SZOR DJ, Dias AR, Pereira MA, Ramos MFKP, et al
   Reply to: "Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer".
   J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25069.
   PubMed     Text format    
   
   
   May 2018
5. KIM HS, Chon HJ, Kim H, Shin SJ, et al
   MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
   J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25097.
   PubMed     Text format     Abstract available
   
   
   
6. WEN J, Bedford M, Begum R, Mitchell H, et al
   The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
   J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25057.
   PubMed     Text format     Abstract available
   
   
   March 2018
7. PEREIRA MA, Ramos MFKP, Faraj SF, Dias AR, et al
   Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
   J Surg Oncol. 2018 Mar 13. doi: 10.1002/jso.25022.
   PubMed     Text format     Abstract available
   
   
   
8. MARTINS MR, Santos RLD, Jatahy KDN, Matta MCD, et al
   Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?
   J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.25001.
   PubMed     Text format     Abstract available
   
   
   
9. SZOR DJ, Roncon Dias A, Pereira MA, Ramos MFKP, et al
   Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer.
   J Surg Oncol. 2018 Mar 6. doi: 10.1002/jso.25036.
   PubMed     Text format     Abstract available
   
   
   
10. MIZRAK KAYA D, Nogueras-Gonzalez GM, Harada K, Amlashi FG, et al
    Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
    J Surg Oncol. 2018;117:678-684.
    PubMed     Text format     Abstract available
    
    
    
11. GABRIEL E, Attwood K, Narayanan S, Brady M, et al
    Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?
    J Surg Oncol. 2018;117:659-670.
    PubMed     Text format     Abstract available
    
    
    January 2018
12. NISHIZUKA SS, Tamura G, Nakatochi M, Fukushima N, et al
    Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24977.
    PubMed     Text format     Abstract available
    
    
    December 2017
13. MURATA S, Yamamoto H, Shimizu T, Naitoh H, et al
    5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24906.
    PubMed     Text format     Abstract available
    
    
    
14. IKOMA N, Cloyd J, Badgwell BD, Agnes A, et al
    Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24926.
    PubMed     Text format     Abstract available
    
    
    
15. LI K, Cannon JGD, Jiang SY, Sambare TD, et al
    Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis.
    J Surg Oncol. 2017 Dec 4. doi: 10.1002/jso.24942.
    PubMed     Text format     Abstract available
    
    
    
16. LEE JH, Tanaka E, Woo Y, Ali G, et al
    Advanced real-time multi-display educational system (ARMES): An innovative real-time audiovisual mentoring tool for complex robotic surgery.
    J Surg Oncol. 2017;116:894-897.
    PubMed     Text format     Abstract available
    
    
    November 2017
17. LIU X, Li G, Long Z, Yin J, et al
    Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24917.
    PubMed     Text format     Abstract available
    
    
    
18. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Text format     Abstract available
    
    
    August 2017
19. DUAN W, Liu K, Fu X, Shen X, et al
    Semi-end-to-end esophagojejunostomy after laparoscopy-assisted total gastrectomy better reduces stricture and leakage than the conventional end-to-side procedure: A retrospective study.
    J Surg Oncol. 2017;116:177-183.
    PubMed     Text format     Abstract available
    
    
    July 2017
20. MURATA S, Yamamoto H, Naitoh H, Yamaguchi T, et al
    Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.
    J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24771.
    PubMed     Text format     Abstract available
    
    
    
21. CHEN XD, Mao CC, Zhang WT, Lin J, et al
    A quantified risk-scoring system and rating model for postsurgical gastroparesis syndrome in gastric cancer patients.
    J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24691.
    PubMed     Text format     Abstract available
    
    
    June 2017
22. SON SY, Kong SH, Ahn HS, Park YS, et al
    The value of N staging with the positive lymph node ratio, and splenectomy, for remnant gastric cancer: A multicenter retrospective study.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24737.
    PubMed     Text format     Abstract available
    
    
    
23. SAUNDERS JH, Bowman CR, Reece-Smith AM, Pang V, et al
    The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery.
    J Surg Oncol. 2017;115:821-829.
    PubMed     Text format     Abstract available
    
    
    May 2017
24. BUSWEILER LAD, Dikken JL, Henneman D, van Berge Henegouwen MI, et al
    The influence of a composite hospital volume on outcomes for gastric cancer surgery: A Dutch population-based study.
    J Surg Oncol. 2017 May 15. doi: 10.1002/jso.24562.
    PubMed     Text format     Abstract available
    
    
    
25. LORENZON L, Cippitelli C, Avantifiori R, Uccini S, et al
    Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system.
    J Surg Oncol. 2017 May 5. doi: 10.1002/jso.24648.
    PubMed     Text format     Abstract available
    
    
    March 2017
26. GIULIANO K, Nagarajan N, Canner J, Najafian A, et al
    Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ?
    J Surg Oncol. 2017;115:351-357.
    PubMed     Text format     Abstract available
    
    
    February 2017
27. RUSSO A, Li P, Strong VE
    Differences in the multimodal treatment of gastric cancer: East versus west.
    J Surg Oncol. 2017 Feb 9. doi: 10.1002/jso.24517.
    PubMed     Text format     Abstract available
    
    
    December 2016
28. RONA KA, Schwameis K, Zehetner J, Samakar K, et al
    Gastric cancer in the young: An advanced disease with poor prognostic features.
    J Surg Oncol. 2016 Dec 23. doi: 10.1002/jso.24533.
    PubMed     Text format     Abstract available
    
    
    November 2016
29. FEINGOLD PL, Kwong ML, Davis JL, Rudloff U, et al
    Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.
    J Surg Oncol. 2016 Nov 23. doi: 10.1002/jso.24476.
    PubMed     Text format     Abstract available
    
    
    
30. POLOM K, Marrelli D, Roviello G, Pascale V, et al
    Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability.
    J Surg Oncol. 2016 Nov 18. doi: 10.1002/jso.24513.
    PubMed     Text format     Abstract available
    
    
    October 2016
31. IMAMURA T, Komatsu S, Ichikawa D, Kawaguchi T, et al
    Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis.
    J Surg Oncol. 2016;114:607-612.
    PubMed     Text format     Abstract available
    
    
    
32. EL-HAGE A, Ruel C, Afif W, Wissanji H, et al
    Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastases.
    J Surg Oncol. 2016;114:543-547.
    PubMed     Text format     Abstract available
    
    
    
33. POSTLEWAIT LM, Baptiste GG, Ethun CG, Le N, et al
    A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
    J Surg Oncol. 2016;114:576-580.
    PubMed     Text format     Abstract available
    
    
    September 2016
34. GERTLER R, Richter J, Stecher L, Nitsche U, et al
    What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    J Surg Oncol. 2016;114:428-33.
    PubMed     Text format     Abstract available
    
    
    
35. RUSSELL MC
    Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.
    J Surg Oncol. 2016;114:296-303.
    PubMed     Text format     Abstract available
    
    
    August 2016
36. CHANG JS, Kim KH, Keum KC, Noh SH, et al
    Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.
    J Surg Oncol. 2016 Aug 11. doi: 10.1002/jso.24405.
    PubMed     Text format     Abstract available
    
    
    
37. BAPTISTE GG, Postlewait LM, Ethun CG, Le N, et al
    Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    J Surg Oncol. 2016;114:163-9.
    PubMed     Text format     Abstract available
    
    
    July 2016
38. HUH CW, Jung DH, Kim H, Kim H, et al
    Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer.
    J Surg Oncol. 2016 Jul 22. doi: 10.1002/jso.24385.
    PubMed     Text format     Abstract available
    
    
    
39. IKOMA N, Blum M, Chiang YJ, Estrella JS, et al
    Survival rates in T1 and T2 gastric cancer: A Western report.
    J Surg Oncol. 2016 Jul 20. doi: 10.1002/jso.24382.
    PubMed     Text format     Abstract available
    
    
    June 2016
40. HERRERA-ALMARIO G, Patane M, Sarkaria I, Strong VE, et al
    Initial report of near-infrared fluorescence imaging as an intraoperative adjunct for lymph node harvesting during robot-assisted laparoscopic gastrectomy.
    J Surg Oncol. 2016;113:768-70.
    PubMed     Text format     Abstract available
    
    
    May 2016
41. BLACKHAM AU, Greenleaf E, Yamamoto M, Hollenbeak C, et al
    Tumor regression grade in gastric cancer: Predictors and impact on outcome.
    J Surg Oncol. 2016 May 20. doi: 10.1002/jso.24307.
    PubMed     Text format     Abstract available
    
    
    
42. SERRANO OK, Love C, Goldman I, Huang K, et al
    The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
    J Surg Oncol. 2016;113:640-6.
    PubMed     Text format     Abstract available
    
    
    April 2016
43. LI HZ, Chen JX, Zheng Y, Zhu XN, et al
    Laparoscopic-assisted versus open radical gastrectomy for resectable gastric cancer: Systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.
    J Surg Oncol. 2016 Apr 13. doi: 10.1002/jso.24243.
    PubMed     Text format     Abstract available
    
    
    
44. CAO L, Selby LV, Hu X, Zhang Y, et al
    Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.
    J Surg Oncol. 2016 Apr 4. doi: 10.1002/jso.24228.
    PubMed     Text format     Abstract available
    
    
    
45. FUENTES E, Ahmad R, Hong TS, Clark JW, et al
    The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.
    J Surg Oncol. 2016;113:560-4.
    PubMed     Text format     Abstract available
    
    
    March 2016
46. RANDLE RW, Swords DS, Levine EA, Fino NF, et al
    Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    J Surg Oncol. 2016 Mar 21. doi: 10.1002/jso.24227.
    PubMed     Text format     Abstract available
    
    
    
47. WANG G, Jiang Z, Zhao J, Liu J, et al
    Assessing the safety and efficacy of full robotic gastrectomy with intracorporeal robot-sewn anastomosis for gastric cancer: A randomized clinical trial.
    J Surg Oncol. 2016;113:397-404.
    PubMed     Text format     Abstract available
    
    
    February 2016
48. RESLINGER V, Tranchart H, D'Annunzio E, Poghosyan T, et al
    Esophageal reconstruction by colon interposition after esophagectomy for cancer analysis of current indications, operative outcomes, and long-term survival.
    J Surg Oncol. 2016;113:159-64.
    PubMed     Text format     Abstract available
    
    
    January 2016
49. LAKS S, Myers MO
    Increased complications associated with feeding jejunostomy in gastrectomy for gastric cancer: Chicken or the egg?
    J Surg Oncol. 2016;113:120.
    PubMed     Text format    
    
    
    
50. POSTLEWAIT LM, Maithel SK
    Response: increased complications associated with feeding jejunostomy in gastrectomy for gastric cancer: Chicken or the egg?
    J Surg Oncol. 2016;113:121.
    PubMed     Text format    
    
    
    
51. SERRANO OK, Huang K, Ng N, Yang J, et al
    Correlation between preoperative endoscopic ultrasound and surgical pathology staging of gastric adenocarcinoma: A single institution retrospective review.
    J Surg Oncol. 2016;113:42-5.
    PubMed     Text format     Abstract available
    
    
    
52. SHIOZAKI H, Elimova E, Slack RS, Chen HC, et al
    Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.
    J Surg Oncol. 2016;113:29-35.
    PubMed     Text format     Abstract available
    
    
    December 2015
53. BOGER C, Behrens HM, Rocken C
    Ki67-An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity.
    J Surg Oncol. 2015 Dec 28. doi: 10.1002/jso.24104.
    PubMed     Text format     Abstract available
    
    
    
54. POSTLEWAIT LM, Maithel SK
    The importance of surgical margins in gastric cancer.
    J Surg Oncol. 2015 Dec 10. doi: 10.1002/jso.24110.
    PubMed     Text format     Abstract available
    
    
    November 2015
55. OKABE H, Hata H, Ueda S, Zaima M, et al
    A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
    J Surg Oncol. 2015 Nov 25. doi: 10.1002/jso.24096.
    PubMed     Text format     Abstract available
    
    
    
56. ECKER BL, Datta J, McMillan MT, Poe SL, et al
    Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.
    J Surg Oncol. 2015;112:616-21.
    PubMed     Text format     Abstract available
    
    
    October 2015
57. TRAN TB, Hatzaras I, Worhunsky DJ, Vitiello GA, et al
    Gastric remnant cancer: A distinct entity or simply another proximal gastric cancer?
    J Surg Oncol. 2015 Oct 29. doi: 10.1002/jso.24080.
    PubMed     Text format     Abstract available
    
    
    
58. SAITO T, Kurokawa Y, Miyazaki Y, Makino T, et al
    Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation?
    J Surg Oncol. 2015 Oct 13. doi: 10.1002/jso.24067.
    PubMed     Text format     Abstract available
    
    
    September 2015
59. SUENAGA M, Yamada S, Fuchs BC, Fujii T, et al
    CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
    J Surg Oncol. 2015 Sep 28. doi: 10.1002/jso.24056.
    PubMed     Text format     Abstract available
    
    
    
60. HUR H, Kim YB, Ham IH, Lee D, et al
    Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
    J Surg Oncol. 2015 Sep 18. doi: 10.1002/jso.24043.
    PubMed     Text format     Abstract available
    
    
    August 2015
61. TEGELS JJ, van Vugt JL, Reisinger KW, Hulsewe KW, et al
    Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
    J Surg Oncol. 2015 Aug 31. doi: 10.1002/jso.24015.
    PubMed     Text format     Abstract available
    
    
    
62. NIENHUESER H, Kunzmann R, Sisic L, Blank S, et al
    Surgery of gastric cancer and esophageal cancer: Does age matter?
    J Surg Oncol. 2015 Aug 25. doi: 10.1002/jso.24004.
    PubMed     Text format     Abstract available
    
    
    
63. POSTLEWAIT LM, Squires MH 3rd, Kooby DA, Poultsides GA, et al
    The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative.
    J Surg Oncol. 2015 Aug 14. doi: 10.1002/jso.23971.
    PubMed     Text format     Abstract available
    
    
    
64. ASHFAQ A, Kidwell JT, McGhan LJ, Dueck AC, et al
    Validation of a gastric cancer nomogram using a cancer registry.
    J Surg Oncol. 2015 Aug 14. doi: 10.1002/jso.23999.
    PubMed     Text format     Abstract available
    
    
    
65. KOBAYASHI D, Iwata N, Tanaka C, Kanda M, et al
    Factors related to occurrence and aggravation of pancreatic fistula after radical gastrectomy for gastric cancer.
    J Surg Oncol. 2015 Aug 8. doi: 10.1002/jso.24001.
    PubMed     Text format     Abstract available
    
    
    
66. DANN GC, Squires MH 3rd, Postlewait LM, Kooby DA, et al
    An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative.
    J Surg Oncol. 2015 Aug 4. doi: 10.1002/jso.23983.
    PubMed     Text format     Abstract available
    
    
    July 2015
67. SUN Z, Nussbaum DP, Speicher PJ, Czito BG, et al
    Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
    J Surg Oncol. 2015 Jul 14. doi: 10.1002/jso.23957.
    PubMed     Text format     Abstract available
    
    
    
68. STRONG VE, Wu AW, Selby LV, Gonen M, et al
    Differences in gastric cancer survival between the U.S. and China.
    J Surg Oncol. 2015 Jul 14. doi: 10.1002/jso.23940.
    PubMed     Text format     Abstract available
    
    
    June 2015
69. PETRELLI F, Coinu A, Cabiddu M, Ghilardi M, et al
    Hepatic resection for gastric cancer liver metastases: A systematic review and meta-analysis.
    J Surg Oncol. 2015 Jun 16. doi: 10.1002/jso.23920.
    PubMed     Text format     Abstract available
    
    
    
70. GADDE R, Tamariz L, Hanna M, Avisar E, et al
    Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis.
    J Surg Oncol. 2015 Jun 12. doi: 10.1002/jso.23945.
    PubMed     Text format     Abstract available
    
    
    
71. PENG YF, Imano M, Itoh T, Satoh T, et al
    A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer.
    J Surg Oncol. 2015 Jun 7. doi: 10.1002/jso.23928.
    PubMed     Text format     Abstract available
    
    
    
72. BADGWELL B, Roy-Chowdhuri S, Chiang YJ, Matamoros A, et al
    Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery.
    J Surg Oncol. 2015;111:875-81.
    PubMed     Text format     Abstract available
    
    
    May 2015
73. SON T, Hyung WJ
    Robotic gastrectomy for gastric cancer.
    J Surg Oncol. 2015 May 29. doi: 10.1002/jso.23926.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: